Biogen IncNASDAQ:BIIB
- LAST PRICE229.8000
- TODAY'S CHANGE (%)4.8600 (2.1606%)
- Bid / Lots223.0000/ 1
- Ask / Lots233.0500/ 1
- Open / Previous Close225.3000 / 224.9400
- Day Range
- 52 Week Range
- Volume1,167,261
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BIIB |
|---|---|---|
| 09:32 ET | 10301 | 224.74 |
| 09:34 ET | 1200 | 225.43 |
| 09:36 ET | 2341 | 227.22 |
| 09:38 ET | 2002 | 227.415 |
| 09:39 ET | 936 | 227.04 |
| 09:41 ET | 1000 | 227.23 |
| 09:43 ET | 9587 | 227.425 |
| 09:45 ET | 3143 | 226.91 |
| 09:48 ET | 4751 | 227.435 |
| 09:50 ET | 4640 | 228.72 |
| 09:52 ET | 2042 | 229.47 |
| 09:54 ET | 4210 | 229.385 |
| 09:56 ET | 2905 | 229.55 |
| 09:57 ET | 2126 | 229.98 |
| 09:59 ET | 10810 | 229.48 |
| 10:01 ET | 1776 | 229.705 |
| 10:03 ET | 2927 | 230.25 |
| 10:06 ET | 1226 | 230.56 |
| 10:08 ET | 3034 | 230.71 |
| 10:10 ET | 1326 | 230.86 |
| 10:12 ET | 1340 | 230.42 |
| 10:14 ET | 695 | 230.48 |
| 10:15 ET | 2070 | 230.38 |
| 10:17 ET | 2184 | 230.24 |
| 10:19 ET | 1026 | 230.63 |
| 10:21 ET | 1777 | 230.29 |
| 10:24 ET | 5318 | 231.1 |
| 10:26 ET | 610 | 231.26 |
| 10:28 ET | 3417 | 231.385 |
| 10:30 ET | 3136 | 230.99 |
| 10:32 ET | 2163 | 231.23 |
| 10:33 ET | 1692 | 231.05 |
| 10:35 ET | 1489 | 230.83 |
| 10:37 ET | 1770 | 231.22 |
| 10:39 ET | 2287 | 231.04 |
| 10:42 ET | 2585 | 231.36 |
| 10:44 ET | 3880 | 231.785 |
| 10:46 ET | 4116 | 231.56 |
| 10:48 ET | 2520 | 232.06 |
| 10:50 ET | 4264 | 231.925 |
| 10:51 ET | 2146 | 231.635 |
| 10:53 ET | 3800 | 231.185 |
| 10:55 ET | 3100 | 230.97 |
| 10:57 ET | 2667 | 231.67 |
| 11:00 ET | 9450 | 231.72 |
| 11:02 ET | 2350 | 232.29 |
| 11:04 ET | 13856 | 232.85 |
| 11:06 ET | 10192 | 232.205 |
| 11:08 ET | 5775 | 232.15 |
| 11:09 ET | 2340 | 232.41 |
| 11:11 ET | 2234 | 232.365 |
| 11:13 ET | 3771 | 232.64 |
| 11:15 ET | 2411 | 232.58 |
| 11:18 ET | 7730 | 232.96 |
| 11:20 ET | 1286 | 233.19 |
| 11:22 ET | 1100 | 233.04 |
| 11:24 ET | 6127 | 232.71 |
| 11:26 ET | 200 | 232.775 |
| 11:27 ET | 4323 | 232.22 |
| 11:29 ET | 2937 | 232.49 |
| 11:31 ET | 2268 | 231.325 |
| 11:33 ET | 1100 | 230.47 |
| 11:36 ET | 4380 | 230.51 |
| 11:38 ET | 2200 | 230.04 |
| 11:40 ET | 925 | 230.015 |
| 11:42 ET | 2000 | 229.555 |
| 11:44 ET | 1500 | 229.46 |
| 11:45 ET | 500 | 228.97 |
| 11:47 ET | 2900 | 229.28 |
| 11:49 ET | 1800 | 229.295 |
| 11:51 ET | 2069 | 229.24 |
| 11:54 ET | 3627 | 229.21 |
| 11:56 ET | 4387 | 228.5 |
| 11:58 ET | 3018 | 228.52 |
| 12:00 ET | 1400 | 228.475 |
| 12:02 ET | 2196 | 228.84 |
| 12:03 ET | 864 | 228.615 |
| 12:05 ET | 991 | 228.38 |
| 12:07 ET | 3775 | 228.58 |
| 12:09 ET | 1025 | 228.365 |
| 12:12 ET | 1955 | 228.69 |
| 12:14 ET | 700 | 227.915 |
| 12:16 ET | 1100 | 228.21 |
| 12:18 ET | 5593 | 227.895 |
| 12:20 ET | 2300 | 228.19 |
| 12:21 ET | 549 | 228.07 |
| 12:23 ET | 1280 | 228.31 |
| 12:25 ET | 300 | 228.23 |
| 12:27 ET | 400 | 228.07 |
| 12:30 ET | 400 | 228.075 |
| 12:32 ET | 1560 | 228.06 |
| 12:34 ET | 8600 | 227.94 |
| 12:36 ET | 4131 | 228.035 |
| 12:38 ET | 5168 | 227.975 |
| 12:39 ET | 1557 | 228.41 |
| 12:41 ET | 1093 | 228.75 |
| 12:43 ET | 1391 | 228.37 |
| 12:45 ET | 889 | 228.43 |
| 12:48 ET | 300 | 228.14 |
| 12:50 ET | 2368 | 228.16 |
| 12:52 ET | 1075 | 227.905 |
| 12:54 ET | 3225 | 227.955 |
| 12:56 ET | 800 | 228.345 |
| 12:57 ET | 1930 | 228.21 |
| 12:59 ET | 310 | 228.355 |
| 01:01 ET | 1400 | 228.38 |
| 01:03 ET | 962 | 228.25 |
| 01:06 ET | 400 | 228.155 |
| 01:08 ET | 1093 | 228.2 |
| 01:10 ET | 1746 | 228.02 |
| 01:12 ET | 6046 | 228.1875 |
| 01:14 ET | 2704 | 228.68 |
| 01:15 ET | 4206 | 229.12 |
| 01:17 ET | 1300 | 229.45 |
| 01:19 ET | 4459 | 229.79 |
| 01:21 ET | 4475 | 229.725 |
| 01:24 ET | 1919 | 230.08 |
| 01:26 ET | 1650 | 229.79 |
| 01:28 ET | 1590 | 229.88 |
| 01:30 ET | 1400 | 229.71 |
| 01:32 ET | 500 | 229.96 |
| 01:33 ET | 1939 | 230.41 |
| 01:35 ET | 4076 | 230.77 |
| 01:37 ET | 900 | 230.595 |
| 01:39 ET | 2863 | 230.53 |
| 01:42 ET | 2938 | 231 |
| 01:44 ET | 800 | 231.105 |
| 01:46 ET | 1500 | 231 |
| 01:48 ET | 800 | 230.89 |
| 01:50 ET | 320 | 230.805 |
| 01:51 ET | 900 | 230.745 |
| 01:53 ET | 1200 | 230.65 |
| 01:55 ET | 511 | 230.73 |
| 01:57 ET | 200 | 230.83 |
| 02:00 ET | 2185 | 230.76 |
| 02:02 ET | 715 | 230.89 |
| 02:04 ET | 950 | 230.7725 |
| 02:06 ET | 1200 | 231.04 |
| 02:08 ET | 2363 | 230.845 |
| 02:09 ET | 900 | 230.875 |
| 02:11 ET | 744 | 230.76 |
| 02:13 ET | 1109 | 230.53 |
| 02:15 ET | 600 | 230.32 |
| 02:18 ET | 1242 | 230.475 |
| 02:20 ET | 710 | 230.54 |
| 02:22 ET | 2571 | 230.835 |
| 02:24 ET | 1031 | 231.02 |
| 02:26 ET | 476 | 230.85 |
| 02:27 ET | 1000 | 230.69 |
| 02:29 ET | 1200 | 230.48 |
| 02:31 ET | 1513 | 230.42 |
| 02:33 ET | 1800 | 231.065 |
| 02:36 ET | 533 | 230.845 |
| 02:38 ET | 250 | 230.65 |
| 02:40 ET | 5400 | 230.69 |
| 02:42 ET | 1400 | 231.06 |
| 02:44 ET | 1741 | 231.11 |
| 02:45 ET | 1025 | 231.24 |
| 02:47 ET | 673 | 231.23 |
| 02:49 ET | 959 | 231.145 |
| 02:51 ET | 852 | 231.09 |
| 02:54 ET | 797 | 231.02 |
| 02:56 ET | 2598 | 231.31 |
| 02:58 ET | 1056 | 231.1 |
| 03:00 ET | 400 | 231.16 |
| 03:02 ET | 2812 | 230.665 |
| 03:03 ET | 200 | 230.64 |
| 03:05 ET | 488 | 230.12 |
| 03:07 ET | 1300 | 230.12 |
| 03:09 ET | 1395 | 230.2 |
| 03:12 ET | 859 | 230.31 |
| 03:14 ET | 684 | 230.125 |
| 03:16 ET | 714 | 230.29 |
| 03:18 ET | 1000 | 230.36 |
| 03:20 ET | 1120 | 230.56 |
| 03:21 ET | 1600 | 230.67 |
| 03:23 ET | 1301 | 230.38 |
| 03:25 ET | 600 | 230.455 |
| 03:27 ET | 100 | 230.415 |
| 03:30 ET | 1300 | 230.04 |
| 03:32 ET | 600 | 229.875 |
| 03:34 ET | 1966 | 230.275 |
| 03:36 ET | 3619 | 230.18 |
| 03:38 ET | 1742 | 230.44 |
| 03:39 ET | 3382 | 229.935 |
| 03:41 ET | 820 | 229.675 |
| 03:43 ET | 2300 | 229.305 |
| 03:45 ET | 2543 | 229.24 |
| 03:48 ET | 1950 | 229.29 |
| 03:50 ET | 2447 | 229.245 |
| 03:52 ET | 5341 | 229.375 |
| 03:54 ET | 4295 | 229.235 |
| 03:56 ET | 8290 | 229.2 |
| 03:57 ET | 9360 | 229.33 |
| 03:59 ET | 29115 | 229.8 |
Today
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc.(BIIB) Shareholders, from 27 minutes ago by Dow Jones
27 minutes ago by Dow JonesBIOGEN 50 DAY NOTICE: Investors of Biogen Inc. (Nasdaq: BIIB) are Encouraged to Contact BFA Law Before July 2024 Deadline in Securities Fraud Class Action, from 54 minutes ago by Dow Jones
54 minutes ago by Dow JonesBiogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB), from 1 hour ago by Dow Jones
1 hour ago by Dow JonesLevi & Korsinsky Reminds Biogen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 - BIIB, from 1 hour ago by Dow Jones
1 hour ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biogen Inc | 32.8B | 28.7x | -18.14% |
ICON PLC | 26.9B | 39.3x | +4.68% |
Grifols SA | 6.2B | 75.2x | --- |
IQVIA Holdings Inc | 39.9B | 29.5x | +46.62% |
Biontech SE | 23.9B | 199.5x | --- |
Moderna Inc | 54.6B | -9.4x | --- |
Company Information
Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. It also has collaborations for the commercialization of LEQEMBI, ZURZUVAE, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS, LUNSUMIO, and COLUMVI. It commercializes a portfolio of biosimilars of advanced biologics including BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ.
Contact Information
- Headquarters
- 225 Binney StreetCAMBRIDGE, MA, United States 02142
- Phone
- 781-464-2000
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Caroline Dorsa
- President, Chief Executive Officer, Director
- Christopher Viehbacher
- Chief Financial Officer, Executive Vice President
- Michael McDonnell
- Chief Human Resource Officer, Executive Vice President
- Ginger Gregory
- Executive Vice President, Chief Legal Officer, Secretary
- Susan Alexander
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.8B |
|---|---|
Revenue (TTM) | $9.7B |
Shares Outstanding | 145.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.02 |
EPS | $8.00 |
Book Value | $102.14 |
P/E Ratio | 28.7x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 19.3x |
Operating Margin | 17.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
